Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Oct 1, 2021

Accession no.
0001209191-21-058521
Filed
Oct 1, 2021
Trade date
Sep 1-30, 2021
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $891.15. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2021Common StockPPurchaseAcquired+15$2.88+$43.213,373Direct
Sep 2, 2021Common StockPPurchaseAcquired+15$2.88+$43.213,388Direct
Sep 3, 2021Common StockPPurchaseAcquired+15$2.85+$42.7513,403Direct
Sep 7, 2021Common StockPPurchaseAcquired+15$2.79+$41.8513,418Direct
Sep 8, 2021Common StockPPurchaseAcquired+15$2.89+$43.3513,433Direct
Sep 9, 2021Common StockPPurchaseAcquired+15$2.77+$41.5513,448Direct
Sep 10, 2021Common StockPPurchaseAcquired+15$2.78+$41.713,463Direct
Sep 13, 2021Common StockPPurchaseAcquired+15$2.96+$44.413,478Direct
Sep 14, 2021Common StockPPurchaseAcquired+15$3.02+$45.313,493Direct
Sep 15, 2021Common StockPPurchaseAcquired+15$2.86+$42.913,508Direct
Sep 16, 2021Common StockPPurchaseAcquired+15$2.91+$43.6513,523Direct
Sep 17, 2021Common StockPPurchaseAcquired+15$2.85+$42.7513,538Direct
Sep 20, 2021Common StockPPurchaseAcquired+15$2.82+$42.313,553Direct
Sep 21, 2021Common StockPPurchaseAcquired+15$2.81+$42.1513,568Direct
Sep 22, 2021Common StockPPurchaseAcquired+15$2.76+$41.413,583Direct
Sep 23, 2021Common StockPPurchaseAcquired+15$2.75+$41.2513,598Direct
Sep 24, 2021Common StockPPurchaseAcquired+15$2.74+$41.113,613Direct
Sep 27, 2021Common StockPPurchaseAcquired+15$2.79+$41.8513,628Direct
Sep 28, 2021Common StockPPurchaseAcquired+15$2.76+$41.413,643Direct
Sep 29, 2021Common StockPPurchaseAcquired+15$2.82+$42.313,658Direct
Sep 30, 2021Common StockPPurchaseAcquired+15$2.72+$40.813,673Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)